Aphria NASDAQ: APHA
Aphria Inc. produces and sells medical cannabis in Canada and internationally
Name | Aphria |
Ticker | APHA |
Exchange | NASDAQ |
Sector | Health Care |
Industry | Cannabis Producer |
Price
52W Low/High |
17.84
2.13 / 26.30 |
Momentum | Strong Up |
Market cap | 4.5 B |
1Y Total Return |
387.43%
Strong |
1Y Volatility |
100.06%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Aphria Inc. produces and sells medical cannabis in Canada and internationally
Details
Ticker | APHA |
Name | Aphria |
ISIN | CA03765K1049 |
CUSIP | 03765K104 |
Exchange | NASDAQ |
Sector | Health Care |
Industry | Cannabis Producer |
Country | Canada |
Currency | U.S. Dollar |
Share as of 2/26/21
Close Price | 17.84 |
52W Low/High | 2.13 / 26.30 |
Market cap | 4.5 B |
1Y Total Return |
387.43%
Strong |
1Y Volatility |
100.06%
High Risk |
Beta | 1.62 |
PE (trailing) | - |
12M Dividends | - |
Last Dividend Date | - |
Dividend Yield | - |
Fin. Strength
Net Profit Margin | -15.6% |
Cash from Op. / Cur. Liabilities | -0.79 |
Diluted Earnings / Share | -0.24 |
ROE | - |
ROIC | -3.7% |
Price / Revenue | 11.7 |
Price / Book | 3.5 |
Price / CF | -47.5 |
Current Ratio | 5.3 |
Cur.Liabilities / Tot.Liabilities | 0.3 |
Financial Leverage | 0.23 |
in Mils USD |
rolling-year up to June
|
||||
---|---|---|---|---|---|
Income Statement | 2020 | 2019 | 2018 | 2017 | |
Revenue |
394
|
177
|
29
|
15
|
|
Gross Profit |
139
|
56
|
32
|
13
|
|
R&D |
2
|
1
|
0
|
0
|
|
EBITDA |
-4
|
1
|
33
|
5
|
|
Operating Income |
-48
|
-108
|
-10
|
-1
|
|
Net Income exc. Extra |
-
|
-
|
23
|
3
|
|
per Share | |||||
Diluted avg Shares |
258
|
243
|
166
|
111
|
|
EPS exc. Extra |
-0.24
|
-0.05
|
0.14
|
0.03
|
|
Dividend |
-
|
-
|
-
|
-
|
|
Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
Balance Sheet | 2020 | 2019 | 2018 | 2017 | |
Total Assets |
1,810
|
1,822
|
1,019
|
234
|
|
Cash, Eq & Invt ShortTerm |
371
|
464
|
83
|
124
|
|
Total Current Assets |
655
|
583
|
151
|
133
|
|
Total Non-Current Assets |
1,156
|
1,239
|
868
|
101
|
|
Intangibles |
711
|
792
|
581
|
2
|
|
Total Liabilities |
478
|
529
|
109
|
31
|
|
Total Current Liabilities |
123
|
103
|
34
|
8
|
|
Long Term Debt |
355
|
425
|
75
|
24
|
|
Shareholder equity |
1,313
|
1,272
|
902
|
203
|
|
Cash Flow | 2020 | 2019 | 2018 | 2017 | |
Cash from Operations |
-97
|
-41
|
-4
|
4
|
|
Depreciation |
36
|
17
|
5
|
1
|
|
Cash from Investing |
-68
|
-133
|
-171
|
-150
|
|
Capex |
95
|
154
|
168
|
50
|
|
Cash from Financing |
126
|
541
|
160
|
193
|
|
Stock Issued |
76
|
189
|
158
|
169
|
|
Debt (LT) Issued |
50
|
351
|
-6
|
24
|
|
Free Cash Flow |
-223
|
-197
|
-142
|
-46
|
|
Ratios | 2020 | 2019 | 2018 | 2017 | |
Net Profit Margin |
-
|
-
|
79.8%
|
20.5%
|
|
NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
Current Ratio |
5.3
|
5.6
|
4.4
|
17.4
|
|
Financial Leverage D/E |
0.23
|
0.29
|
0.03
|
0.12
|
|
Return on Capital Avg |
-3.7%
|
-1.4%
|
-2.7%
|
1.9%
|
|
Return on Shareholder Equity |
-
|
-
|
4.1%
|
1.5%
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available